The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive information.
This rejection became public following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesman has since clarified that the US was demanding access to biological samples for research and commercial gain but was unwilling to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more talks to find a deal agreeable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This development comes after a similar case in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were raised about the security of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost openness and accountability.
According to statements, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, without any corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our people if a new disease outbreak arise."
Sovereignty and International Frameworks
He also said that the American exit from the global health body and its push of one-on-one deals were disrupting systems already established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This mechanism is designed to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage ongoing discussions with our US partners on how future collaboration could be structured in a manner that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that talks need to persist since a large portion of the nation's HIV programmes depended on foreign aid.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," it added.
The situation underscores the complex tensions between receiving vital international aid and protecting a country's data in an ever more data-driven world.